Mopping Up Excess Chemotherapy Drugs

A prototype in-vein device would collect toxic medications before they reach healthy tissues.

ruth williams
| 2 min read
drug sponge

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, ISAYILDIZ

Tackling cancer with chemotherapeutics is a careful balancing act between killing the tumor and preserving the health of other tissues. Indeed, the side effects of some chemotherapeutic agents can be so severe that the desired dose for eradicating a tumor is unusable.

Researchers are therefore working to find ways to maximize dose while minimizing systemic toxicity. One approach currently in clinical trials is to divert blood after it flows through an organ targeted with localized high-dose chemotherapy and send it through a filtration device before the medication can flow to the rest of the body. However, this is an invasive approach and requires the subsequent monitoring of a patient in an intensive care unit.

In search of a more benign procedure, Steven Hetts of the University of California, San Francisco, and colleagues are developing in-vein approaches to capture drugs as they exit the treated organ. One ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • ruth williams

    Ruth Williams

    Ruth is a freelance journalist.

Published In

The Scientist April 2019 Issue
April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide